Jon Lim, FRCP PhD

My main PhD paper is finally out! 🎉 After ~5 years, it’s published today in 𝘕𝘢𝘵𝘶𝘳𝘦 𝘐𝘮𝘮𝘶𝘯𝘰𝘭𝘰𝘨𝘺. @natimmunol.nature.com It all started with an unexpected observation 🔍: 👉 Mice lacking the dendritic cell receptor DNGR-1 developed tumours earlier ⏩ and more frequently 📈 than wild-type mice. 1/11 🧵

Attending #ESMO26? 📲 Have you checked out the App? Here’s a useful guide, especially for those who have not used it before - there’s a video demo in the link below 👇 #ESMOAmbassadors

Discover “Targeted cancer #immunotherapy with PD-1 blockade” with Antoni Ribas, recipient of the 2026 ESMO Lifetime Achievement Award, at the #ESMO26 Congress Opening Session. 🔗 https://ow.ly/rQjb50ZXThn

What helps sustain motivation and meaning in oncology? The fostering #resilience under fire session at #ESMO26 explores resilience, professional identity, impostor syndrome and trainable coping skills. 🔗 https://ow.ly/mTBs50ZZK61

The countdown to #ESMO26 begins… looking forward to seeing many colleagues and friends in Madrid 🇪🇸, and the practice-changing data that will be showcased. #ESMOAmbassadors @myesmo.bsky.social

Keep medical doctors in academia — without them, health-care research will suffer www.nature.com/articles/d41...

The #ESMOAmbassadors represent expertise across tumour types and oncology disciplines. Explore their profiles and discover which Ambassadors to follow during #ESMO26. 🔗 https://ow.ly/cyUC50ZOEjF

The challenges shaping our future need connected thinking. See how our Platforms support collaboration across One University 👇 @uomcreativemcr.bsky.social @digitaluom.bsky.social @healthierfutures.bsky.social @sustainableuom.bsky.social

ESMO is pleased to announce the #ESMOAmbassadors for #ESMO26. They will share scientific highlights, expert perspectives and insights on the latest research presented at #ESMO26 across tumour types and disciplines. 🔗Discover the Ambassadors: https://ow.ly/BQ3i50ZOkEv

Great to be here in Suzhou 🇨🇳 this week for #CSHAsia Cancer Immunotherapy meeting. Looking forward to learning from colleagues and discussing science 👇

📣 #ESMO26: Join Prof. James Larkin, Scientific Committee Co-Chair, to exchange perspectives, debate emerging evidence, and discuss the future of cancer prevention, diagnosis, and treatment. ⏰ Late registration deadline: 16 September 2026 🔗 https://ow.ly/q9GM50ZJcZh #esmomeetings

Welcome, Professor Mahima Swamy! 💜 An internationally recognised researcher in intestinal immunology, Professor Swamy has joined the University of Manchester's Lydia Becker Institute as Professor of Immunology, strengthening its world-class expertise in barrier immunity.

WORLD-LEADING IMMUNOLOGIST TAKES UP TOP UOM ROLE ⬇️🦠 Leading immunologist and cytokine biologist, Prof. Sarah Gaffen has been appointed as the new director of The Lydia Becker Institute of Immunology and Inflammation. Welcome, Sarah! 💫 @lydiabeckeriii.bsky.social

Hope you enjoy this short piece, which came out yesterday. Some thoughts I’ve been musing on for a while about why adaptive immunity evolved. Read it for free at rdcu.be/fAO5P

𝗠𝗔𝗡𝗜𝗙𝗘𝗦𝗧 is truly a team effort. 💡 Humbled to hear our very first patient share his perspective. Experiences like his will shape how we scale up & are already helping us learn how more. Watch this space. @manifest-cirrp.bsky.social 📰 As featured today in @theobserveruk.bsky.social 👇

Exciting times in Manchester. Major investment in the CRUK Manchester Institute with eight new groups, including new group leader positions in computational biology and AI www.cruk.manchester.ac.uk/about/new-fu... @cruk-mi.bsky.social

Engineer blood cancer to defeat it!👨‍🔬👩‍🔬 I'm hiring a Senior Scientific Officer at the CRUK Manchester Institute — using CRISPR to recreate the mutation combinations behind AML and MDS, and find where they're vulnerable. Hands-on. Apply 👇 @cruk-mi.bsky.social apps.cruk.manchester.ac.uk/recruitment/...

A great collaboration 🙌 between our Thoracic Oncology, and Advanced Immunotherapy and Cell Therapy teams at The Christie 🐝 - driven by our stellar Senior Clinical Research Fellows Federico Monaca and Rachel Woodford. Available #OpenAccess in 𝘛𝘩𝘦𝘳 𝘈𝘥𝘷 𝘔𝘦𝘥 𝘖𝘯𝘤𝘰𝘭 👇 @christielibrary.bsky.social

🚀 We're building momentum with our RISE programme, and growing our team! Come join us as a 𝗧𝗿𝗮𝗻𝘀𝗹𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗧𝗲𝗰𝗵𝗻𝗶𝗰𝗶𝗮𝗻. Deadline 7th July 2026 👇 @uom-dcs.bsky.social @fbmh-uom.bsky.social @mcrcnews.bsky.social

Great to be in Porto 🇵🇹 for ASPIC International Congress. Looking forward to 2 days of science! Slightly shameless plug: if you’re interested in PhD, postdoc, clinician-scientist, group leader or Clinical Research Fellowship opportunities in Manchester, come say hello 👋 - I’d be happy to chat.

How do donated tissue samples help shape future cancer treatments? Our latest blog explores the work of the MCRC Biobank, which has collected more than 230,000 samples from nearly 30,000 patients to support cutting-edge cancer research. Read more: https://ow.ly/ozuS50Z5EsS

Almost 2️⃣ years in… Our MANIFEST AGM convened scientists, clinicians, patient partners & industry. Keynotes from Prof Levesque & Prof Rattray + Prof Turajlić setting the course ahead. Big thank you to all for continuing to believe in the vision; to tackle the hard questions in #CancerImmunotherapy.

💥 Really pleased to see this story finally out in @natcancer.nature.com. An elegant study built around a very cool concept. Huge congratulations to Tom Castro-Dopico, @reisesousalab.bsky.social and all colleagues involved - delighted to have played a small part in it the journey. @crick.ac.uk

Nice celebration @reisesousalab.bsky.social of our recently published or in press papers. L-R: Tom Castro-Dopico, Oliver Schulz, @drjonlim.bsky.social and Mike Buck. See earlier and forthcoming posts for paper details.

🚨 We're looking for an Associate Director for Strategy & Partnerships — a pivotal leadership role that will help define how we connect, collaborate, and amplify our impact on a global stage of cancer research! Apply below by 26.05.2026! 👇 www.cruk.manchester.ac.uk/career/mi-26... Salary - ~£80,000

Fantastic 2 days in San Diego 🌴 for the inaugural C8 Early Career Investigators Symposium. Happy to represent #TeamManchester + connect with an inspiring group 🌍. A reminder that we’re not navigating academia alone - great to hear re: lessons learned & tips for future 🤝. @mcrcnews.bsky.social

#ESMOTAT26: Drug development in oncology is increasingly moving towards integrated strategies that consider tumour cells, their microenvironment and anatomical context. Read the Opinion by Jon Lim, FRCP PhD in the #ESMODailyReporter 📌 https://ow.ly/fFUx50YJxOP

🚨 Open for applications - Director of Scientific Core Facilities & Services! Shape the strategic future of our core facilities and work with leading experts on cutting-edge cancer discovery and translational research 🧑‍🔬🔬🧪 💷 ~£100,000 ⏰ 17.5.2026 Apply 👉 www.cruk.manchester.ac.uk/career/mi-26...